Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Blood Cancer Journal 6,
e418 (May 2016). doi:10.1038/bcj.2016.27

Authors: Z Chen, W Wang, J E Cortes, E Liu, R N Miranda, C Zhao, J Yuan, X Lu, W Yang, M D Ameri, H M Kantarjian, L J Medeiros & S Hu

Source: Blood Cancer Journal - May 5, 2016 Category: Hematology Authors: Z ChenW WangJ E CortesE LiuR N MirandaC ZhaoJ YuanX LuW YangM D AmeriH M KantarjianL J MedeirosS Hu Source Type: research